Evidence map›Paper›PMID 23857582›Full record

ArticleThe Journal of biological chemistry2013

Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3'-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease.

Michal Mikula, Karol Bomsztyk, Krzysztof Goryca, Krzysztof Chojnowski, Jerzy Ostrowski

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.Journal of the National Cancer Institute · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Michal MikulaDepartment of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland. mikula.michal@gmail.com
Karol Bomsztyk
Krzysztof Goryca
Krzysztof Chojnowski
Jerzy Ostrowski
The Maria Sklodowska-Curie National Research Institute of Oncology · PLPostgraduate School of Molecular Medicine · PLUniversity of Washington · USWarsaw University of Technology · PL

Funding

LAMININ GENE EXPRESSION IN GLOMERULAR CELLSR37DK045978 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2003 to 2011
$2.2M
Acute Renal Failure: An Endotoxin Hyper-Responsive StateR01DK083310 · NIDDK · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL, ZAGER, RICHARD A. · 2010 to 2013
$1.5M
NIDDK NIH HHS R01 DK083310NIDDK NIH HHS R37 DK045978NIDDK NIH HHS R37 DK45978
6 · The paper itself

Abstract

The heterogeneous nuclear ribonucleoprotein K (hnRNPK) is a nucleic acid-binding protein that acts as a docking platform integrating signal transduction pathways to nucleic acid-related processes. Given that hnRNPK could be involved in other steps that compose gene expression the definition of its genome-wide occupancy is important to better understand its role in transcription and co-transcriptional processes. Here, we used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to analyze the genome-wide hnRNPK-DNA interaction in colon cancer cell line HCT116. 9.1/3.6 and 7.0/3.4 million tags were sequenced/mapped, then 1809 and 642 hnRNPK binding sites were detected in quiescent and 30-min serum-stimulated cells, respectively. The inspection of sequencing tracks revealed inducible hnRNPK recruitment along a number of immediate early gene loci, including EGR1 and ZFP36, with the highest densities present at the transcription termination sites. Strikingly, hnRNPK knockdown with siRNA resulted in increased pre-RNA levels transcribed downstream of the EGR1 polyadenylation (A) site suggesting altered 3'-end pre-RNA degradation. Further ChIP survey of hnRNPK knockdown uncovered decreased recruitment of the 5'-3' exonuclease XRN2 along EGR1 and downstream of the poly(A) signal without altering RNA polymerase II density at these sites. Immunoprecipitation of hnRNPK and XRN2 from intact and RNase A-treated nuclear extracts followed by shotgun mass spectrometry revealed the presence of hnRNPK and XRN2 in the same complexes along with other spliceosome-related proteins. Our data suggest that hnRNPK may play a role in recruitment of XRN2 to gene loci thus regulating coupling 3'-end pre-mRNA processing to transcription termination.

Indexed as

3' Untranslated RegionsCell Line, TumorEarly Growth Response Protein 1ExoribonucleasesGene Knockdown TechniquesGenetic LociGenome-Wide Association StudyHeterogeneous-Nuclear Ribonucleoprotein KHumansPoly ARibonucleoproteinsRNA PrecursorsRNA StabilityTranscription Termination, GeneticTristetraprolin3' Untranslated RegionsEarly Growth Response Protein 1EGR1 protein, humanExoribonucleasesHeterogeneous-Nuclear Ribonucleoprotein KHNRNPK protein, humanPoly ARibonucleoproteinsRNA PrecursorsTristetraprolinXRN2 protein, humanZFP36 protein, humanChromatin Immunoprecipitation (ChiP)Gene ExpressionhnRNPKMass Spectrometry (MS)RNA Polymerase IITranscription TerminationXRN2

Identifiers

PMID23857582
PMCPMC3750174
OpenAlexW2004251343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.